Trial Profile
Comparison of helicobacter pylori eradication rate with quadruple therapy containing gemifloxacin versus clarithromycin in dyspeptic patients referring to Rasool Akram Hospital 2013
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 14 Sep 2016
Price :
$35
*
At a glance
- Drugs Clarithromycin (Primary) ; Gemifloxacin (Primary) ; Amoxicillin; Bismuth salicylate; Omeprazole
- Indications Dyspepsia; Helicobacter pylori infections
- Focus Therapeutic Use
- 08 Jun 2013 Recruitment complete, according to the Iranian Registry of Clinical Trials.
- 11 May 2013 Recruitment is expected to complete on the 8th of June 2013
- 11 May 2013 New trial record